Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - NeuroBo Pharmaceuticals, Inc. | gemp-20161231ex3211a9a7b.htm |
| EX-31.2 - EX-31.2 - NeuroBo Pharmaceuticals, Inc. | gemp-20161231ex312866184.htm |
| EX-31.1 - EX-31.1 - NeuroBo Pharmaceuticals, Inc. | gemp-20161231ex3110a4a14.htm |
| 10-K - 10-K - NeuroBo Pharmaceuticals, Inc. | gemp-20161231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Gemphire Therapeutics Inc.
Livonia, Michigan
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-213946 and 333-213014) of Gemphire Therapeutics Inc. of our report dated March 20, 2017, with respect to the financial statements and schedule of Gemphire Therapeutics Inc. included in the Annual Report on Form 10-K for the year ended December 31, 2016.
/s/ ERNST & YOUNG LLP
Detroit, Michigan
March 20, 2017